Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs
Go back to Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs| (NASDAQ: BCTX) | Delayed: 3.04 -0.27 (8.16%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.31 | 52 Week High | $ | |||
| Open | $3.35 | 52 Week Low | $ | |||
| Day High | $3.35 | P/E | N/A | |||
| Day Low | $2.95 | EPS | $ | |||
| Volume | 130,852 | |||||
| (NASDAQ: NTHI) | Delayed: 3.26 +0.14 (4.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.12 | 52 Week High | $ | |||
| Open | $3.16 | 52 Week Low | $ | |||
| Day High | $3.38 | P/E | N/A | |||
| Day Low | $3.10 | EPS | $ | |||
| Volume | 131,692 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $1.37 | |||
| Open | $0.42 | 52 Week Low | $0.24 | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.41 | EPS | $0.00 | |||
| Volume | 764,329 | |||||



